ID

34153

Descrição

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT01246856

Link

https://clinicaltrials.gov/show/NCT01246856

Palavras-chave

  1. 14/01/2019 14/01/2019 -
Titular dos direitos

see on clinicaltrials.gov

Transferido a

14 de janeiro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Breast Cancer NCT01246856

Eligibility Breast Cancer NCT01246856

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
Descrição

ID.1

Tipo de dados

boolean

(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
Descrição

ID.2

Tipo de dados

boolean

Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of breast cancer recurrence or metastatic disease
Descrição

ID.3

Tipo de dados

boolean

evidence of heart disease at the time of breast cancer diagnosis
Descrição

ID.4

Tipo de dados

boolean

evidence of renal failure at the time of cardiac evaluation
Descrição

ID.5

Tipo de dados

boolean

pregnant or lactating
Descrição

ID.6

Tipo de dados

boolean

participation in a research protocol with ionizing radiation within one year before inclusion.
Descrição

ID.7

Tipo de dados

boolean

evidence of diabetes mellitus or parkinson's disease
Descrição

ID.8

Tipo de dados

boolean

evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
Descrição

ID.9

Tipo de dados

boolean

Similar models

Eligibility Breast Cancer NCT01246856

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
boolean
ID.2
Item
(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
evidence of breast cancer recurrence or metastatic disease
boolean
ID.4
Item
evidence of heart disease at the time of breast cancer diagnosis
boolean
ID.5
Item
evidence of renal failure at the time of cardiac evaluation
boolean
ID.6
Item
pregnant or lactating
boolean
ID.7
Item
participation in a research protocol with ionizing radiation within one year before inclusion.
boolean
ID.8
Item
evidence of diabetes mellitus or parkinson's disease
boolean
ID.9
Item
evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
boolean

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial